M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 1.58 USD -1.86% Market Closed
Market Cap: 168.5m USD

Wall Street
Price Targets

MXCT Price Targets Summary
MaxCyte Inc

Wall Street analysts forecast MXCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MXCT is 6.47 USD with a low forecast of 5.05 USD and a high forecast of 9.45 USD.

Lowest
Price Target
5.05 USD
220% Upside
Average
Price Target
6.47 USD
310% Upside
Highest
Price Target
9.45 USD
498% Upside
MaxCyte Inc Competitors:
Price Targets
LAB
Standard BioTools Inc
24% Upside
2268
WuXi XDC Cayman Inc
23% Upside
STVN
Stevanato Group SpA
43% Upside
207940
Samsung Biologics Co Ltd
37% Upside
301333
R&G PharmaStudies Co Ltd
10% Upside
SFZN
Siegfried Holding AG
51% Upside
SHC
Sotera Health Co
9% Upside
ERF
Eurofins Scientific SE
6% Upside

Revenue
Forecast

Revenue Estimate
MaxCyte Inc

For the last 11 years the compound annual growth rate for MaxCyte Inc's revenue is 17%. The projected CAGR for the next 4 years is 16%.

17%
Past Growth
16%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
MaxCyte Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
MaxCyte Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MXCT's stock price target?
Price Target
6.47 USD

According to Wall Street analysts, the average 1-year price target for MXCT is 6.47 USD with a low forecast of 5.05 USD and a high forecast of 9.45 USD.

What is MaxCyte Inc's Revenue forecast?
Projected CAGR
16%

For the last 11 years the compound annual growth rate for MaxCyte Inc's revenue is 17%. The projected CAGR for the next 4 years is 16%.

Back to Top